Stay updated on HMPL-523 in Hematologic Malignancies Clinical Trial
Sign up to get notified when there's something new on the HMPL-523 in Hematologic Malignancies Clinical Trial page.

Latest updates to the HMPL-523 in Hematologic Malignancies Clinical Trial page
- Check6 days agoChange DetectedThe page's UI/navigation text was updated: new labels include Last verified, Last known status was, How to Read a Study Record, Common Questions, How to Join a Study, Intervention/Treatment, and a Revision: v3.6.0 tag. Conversely, older labels such as Verified, Hutchmed ( Hutchison Medipharma Limited ), Last known status was:, Intervention / Treatment, and Revision: v3.5.5 were removed.SummaryDifference1%

- Check13 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5 on the page, indicating a small backend/content management update. The change records the latest revision of the page in the system.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedRevision was updated from v3.5.3 to v3.5.4, indicating a new site build. This change updates the page's revision label to reflect the latest platform version rather than altering trial data or content.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page’s displayed system revision/version has been updated from v3.5.2 to v3.5.3, reflecting a technical update to the ClinicalTrials.gov interface rather than changes to the study information itself.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision: v3.5.2 added; Revision: v3.5.0 removed.SummaryDifference0.1%

- Check70 days agoChange DetectedAdded IQVIA Pty Ltd as a collaborator in the Collaborators and Investigators section and removed the misspelled entry 'Iqvia Pty Ltd' to correct the collaborator list.SummaryDifference0.1%

Stay in the know with updates to HMPL-523 in Hematologic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HMPL-523 in Hematologic Malignancies Clinical Trial page.